Identification of a possible proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSF
Journal article
WINCHESTER L. and NEVADO-HOLGADO A., (2022), Brain Communications
Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerability.
Journal article
Ng B. et al, (2022), Brain Commun, 4
Genome and epigenome wide studies of plasma protein biomarkers for Alzheimer′s disease implicate TBCA and TREM2 in disease risk
Journal article
Hillary RF. et al, (2021)
ANMerge: A comprehensive and accessible Alzheimer’s disease patient-level dataset
Journal article
Birkenbihl C. et al, (2020)
Dysregulated Fc gamma receptor-mediated phagocytosis pathway in Alzheimer's disease: network-based gene expression analysis.
Journal article
Park YH. et al, (2020), Neurobiol Aging, 88, 24 - 32
Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT
Journal article
Howard R. et al, (2020), Efficacy and Mechanism Evaluation, 7, 1 - 62
Tau pathology in early Alzheimer’s disease is linked to selective disruptions in neurophysiological network dynamics
Journal article
Kocagoncu E. et al, (2020), Neurobiology of Aging
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
Journal article
Westwood S. et al, (2020), J Alzheimers Dis, 74, 213 - 225
Will We Have a Drug for Alzheimer's Disease by 2030? The View From Pharma.
Journal article
Lovestone S. and Manji HK., (2020), Clin Pharmacol Ther, 107, 79 - 81
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial.
Journal article
Howard R. et al, (2019), JAMA Neurol
Genetic and Real-World Clinical Data, Combined with Empirical Validation, Nominate Jak-Stat Signaling as a Target for Alzheimer's Disease Therapeutic Development.
Journal article
Nevado-Holgado AJ. et al, (2019), Cells, 8
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease.
Journal article
Ashton NJ. et al, (2019), Sci Adv, 5
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
Journal article
Ten Kate M. et al, (2018), Alzheimers Res Ther, 10
Cross-sectional and longitudinal analyses of outdoor air pollution exposure and cognitive function in UK Biobank.
Journal article
Cullen B. et al, (2018), Sci Rep, 8
Headache and type 2 diabetes association: a US national ambulatory case-control study
Journal article
Nash A. et al, (2018)
Heterogeneous patterns of brain atrophy in Alzheimer's disease.
Journal article
Poulakis K. et al, (2018), Neurobiol Aging, 65, 98 - 108
Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology.
Journal article
Smith RG. et al, (2018), Alzheimers Dement
Imaging Aβ and tau in early stage Alzheimer's disease with [18F]AV45 and [18F]AV1451.
Journal article
Firouzian A. et al, (2018), EJNMMI Res, 8
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.
Journal article
Pardiñas AF. et al, (2018), Nat Genet, 50, 381 - 389
A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.
Journal article
Shi L. et al, (2018), J Alzheimers Dis, 62, 1181 - 1198